ABBVIE INC.

ABBV · Pharmaceutical Preparations · $466.4B
Powering up
ABBV
$263.96
▼ −0.02%
09/18 O 263.29 H 266.34 L 262.44 C 263.96 ▼ −0.02%
Vol 8.2M RS 73
RS rating73
Now vs pivot (%)−1.31%
Tightening (ATR ratio)1.17×
Volume dry-up1.25×
Up/down volume, net0.03
From 52-week high1%
squatforming
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 7.4 weeks and fell 10% from its ceiling at its deepest. The pivot is $267.47, and the stock closed 1.3% below it. Its relative strength rating is 73.

Also on
Peers
Catalyst roadmap
  1. Ex-dividendconfirmedin 27d
    Ex-dividend date
    Oct 15, 2026
  2. Earningstentativein 41d
    Quarterly earnings
    Oct 29, 2026
  3. EarningstentativeLLY · competitorin 41d
    LLY reports
    Oct 29, 2026
  4. EarningstentativeAAPL · industryin 41d
    AAPL reports
    Oct 29, 2026
Flagged by the market sweep

Nothing flagged for this company on the last market sweep.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
ABBVIE INC. (ABBV) — The Tape